JPMorgan (NYSE: AMJB) prices Palantir-linked auto-callable notes with high coupon
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering $250,000 of Auto Callable Contingent Interest Notes linked to the Class A common stock of Palantir Technologies Inc., maturing on June 15, 2027. The notes are issued in $1,000 denominations at a price to public of $1,000, with selling fees of $22.25 per note and net proceeds of $977.75 per note. They pay a contingent coupon of $16.2917 per month per $1,000 (a 19.55% per annum rate) only if Palantir’s share price on a review date is at or above 60% of the initial value of $187.91. The notes are automatically called, starting March 10, 2026, if Palantir’s share price on an eligible review date is at or above the initial value, returning $1,000 plus that period’s coupon.
If the notes are not called and Palantir’s final share price is at or above 50% of the initial value, investors receive $1,000 plus the final coupon; if it is below 50%, repayment is reduced one-for-one with the stock’s loss, and investors can lose most or all principal. The estimated value at pricing was $956.40 per $1,000, below issue price, and investors bear JPMorgan credit risk and limited liquidity, with no stock dividends or voting rights.
Positive
- None.
Negative
- None.
FAQ
What are the key terms of the JPMorgan AMJB notes linked to Palantir?
The notes are Auto Callable Contingent Interest Notes issued by JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., linked to Palantir Technologies Inc. Class A stock. They mature on June 15, 2027, are issued in $1,000 denominations, and target a contingent interest rate of 19.55% per annum, paid monthly when conditions are met.
How do the contingent interest payments work on the AMJB Palantir-linked notes?
For each Review Date, if Palantir’s closing share price is at or above the Interest Barrier of 60% of the initial value ($112.746), each $1,000 note pays a Contingent Interest Payment of $16.2917 (1.62917% per month). If the share price is below the barrier, no interest is paid for that period.
When can the JPMorgan AMJB notes be automatically called?
The notes can be automatically called on any Review Date other than the first, second and final dates, starting on March 10, 2026, if Palantir’s closing price is at least equal to the initial value of $187.91. Upon automatic call, investors receive $1,000 plus the applicable contingent interest, and no further payments are made.
What happens at maturity if the AMJB notes are not automatically called?
If the notes are not called and Palantir’s Final Value is at or above the Trigger Value of 50% of the initial value ($93.955), each $1,000 note pays back $1,000 plus the final contingent interest, if due. If the Final Value is below the Trigger Value, the maturity payment becomes $1,000 + ($1,000 × Stock Return), so investors lose more than 50% of principal and could lose it all.
What are the main risks of investing in the JPMorgan AMJB Palantir-linked notes?
Key risks include: loss of principal if Palantir’s final price falls below the Trigger Value; no guaranteed interest since coupons depend on the stock staying above the Interest Barrier; credit risk of JPMorgan Financial and JPMorgan Chase & Co.; limited liquidity as the notes are not listed; no dividends or voting rights in Palantir; and an estimated value at pricing of $956.40 per $1,000, below the price to public.
How are fees and proceeds structured for the JPMorgan AMJB notes?
Each note has a price to public of $1,000, with fees and commissions of $22.25 per note and proceeds to the issuer of $977.75 per note. For the total $250,000 issuance, selling commissions are $5,562.50 and net proceeds to the issuer are $244,437.50.
What tax treatment does JPMorgan describe for the AMJB Palantir-linked notes?
JPMorgan intends to treat the notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons, and expects Contingent Interest Payments to be taxed as ordinary income. The company notes that alternative treatments are possible and highlights considerations for Non-U.S. Holders, including potential 30% withholding on certain payments, subject to treaty relief and documentation.